Soligenix, Inc.
- SNGX
- NASDAQ
- Biotechnology
- Rare Disease Biopharma
- Public Health Countermeasures
$0.35
Today −2.27%Quote Oct 19, 2026, 01:50 PM UTC
−5.87%over the last month
Max drawdown −13.3%From 1-month high −8.6%3 months −1.5%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$7.5M
Quote Oct 19
Next earnings
Nov 6
Expected, not confirmed
Latest analyst target
—
Data unavailable
Floor
$0.34
0.3% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about SNGXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
14
Founded
1987